Onkar Vaze

Onkar Vaze's email & phone

Opt-Out
Associate Director, Drug Product Formulation Development (CMC) at Spero Therapeutics|Cambridge, Massachusetts, United States

Position:

Associate Director, Drug Product Formulation Development (CMC) at Spero Therapeutics

Location:

Cambridge, Massachusetts, United States

View Onkar Vaze's Email
Up to 10 free lookups. No credit card required.
Last updated: 2023-10-20
Updated: 2023-10-20

Found email addresses for Onkar Vaze:

Found phone for Onkar Vaze:

Searching for Onkar Vaze profiles
0% completed

A different Onkar Vaze?

Sign up to search for other Onkar Vaze's across our 850M+ professionals database

Work Experience 23 years

Associate Director, Drug Product Formulation Development (CMC) at Spero Therapeutics

Jul 2023 - Current

Senior Manager, Drug Product Formulation Development (CMC) at Spero Therapeutics

Jul 2021 - Jul 2023

Scientist II, Pharmaceutical Sciences & Manufacturing (Tech Ops) at Blueprint Medicines

Jan 2020 - Jan 2021

Scientist II, Pharmaceutical Development (CMC) at PTC Therapeutics, Inc.

Jan 2018 - Jan 2020

Scientist I, Pharmaceutical Development (CMC) at PTC Therapeutics, Inc.

Jan 2015 - Jan 2018

Associate Research Scientist II, Preformulations and Formulations (CMC) at PTC Therapeutics, Inc.

Dec 2013 - Dec 2014

Formulation Scientist at Emphascience, Inc.

Jan 2013 - Dec 2013

Post Doctoral Scientist (Industrial) at Boston Biomedical Inc.

Jan 2012 - Dec 2012

Marketing/PR at European Career Fair @ MIT

Sep 2011 - Oct 2012

Graduate Research Assistant at Northeastern University

Sep 2005 - Dec 2011

Clinical Research Associate at Cipla

Jan 2005 - Aug 2005

Pharmaceutical In-plant trainee at Cipla

May 2003 - Jul 2003

Onkar Vaze started working in 2003, then the employee has changed 7 companies and 11 jobs. On average, Onkar Vaze works for one company for 1 year 10 months.

Education

PhD at Northeastern University

Master of Science at Northeastern University

Frequently Asked Questions

What is Onkar Vaze's minimum period of employment in the companies?

Onkar Vaze's minimum period of employment in various companies is 2 months.

What is Onkar Vaze's average duration of employment for different companies?

On average, Onkar Vaze works for one company for 1 year 9 months

What industries has Onkar Vaze worked in?

Onkar Vaze works in the Biotechnology. Previously, Onkar Vaze worked in the Higher Education, and Pharmaceuticals.

What positions has Onkar Vaze held before?

Previously, Onkar Vaze worked as a Senior Manager, Drug Product Formulation Development (CMC), and Scientist II, Pharmaceutical Sciences & Manufacturing (Tech Ops), and Scientist II, Pharmaceutical Development (CMC), and Scientist I, Pharmaceutical Development (CMC), and Associate Research Scientist II, Preformulations and Formulations (CMC).

How do I contact Onkar Vaze?

Onkar Vaze's phone number is +1-***-***-5543. Sign up to get contact details.

Who is the President & CEO of the Spero Therapeutics?

The President & CEO of the Spero Therapeutics is Ankit Mahadevia

Onkar Vaze Namesakes

Name
Company
Position
ONKAR
Self-employed
Owner
Onkar Joshi
S.D. BPO PVT LTD
Managing Director

Other employees at Spero Therapeutics

Name
Company
Position
Aubri Hutchins
Senior Director, Head of Clinical Operations
Jennifer Liscouski
Vice President, Head of Regulatory Affairs
Myriah Satterfield
Director, Clinical Data Management
Maureen
Manager, CRM & Data Management
Terri Facey
Senior Quality Assurance Manager
Akash Jain
Vice President, Alliance Management and Business Development
Tim Keutzer
Chief Operating Officer, Spero Therapeutics

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP